Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as median tumor burden at 95 mg/kg, iv treated once daily for 4 d...

ID: ALA4309312

Type: Functional

Description: Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as median tumor burden at 95 mg/kg, iv treated once daily for 4 days per week for 4 weeks starting from 3 days post implantation and measured at day 60 post last dose (Rvb = 108 mg)

Format: BAO_0000218

Organism: Homo sapiens

Cell type: IGROV-1

Target:  IGROV-1(ALA613984)

Document:  ALA4308835

Antitumor activity against human IGROV1 cells xenografted in NCR SCID mouse assessed as median tumor burden at 95 mg/kg, iv treated once daily for 4 days per week for 4 weeks starting from 3 days post implantation and measured at day 60 post last dose (Rvb = 108 mg): 1